Alambic Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-29,536
Closed -$258K 293
2019
Q4
$258K Buy
29,536
+6,632
+29% +$57.9K 0.22% 180
2019
Q3
$76K Sell
22,904
-15,318
-40% -$50.8K 0.06% 276
2019
Q2
$189K Sell
38,222
-12,400
-24% -$61.3K 0.12% 241
2019
Q1
$314K Sell
50,622
-30,088
-37% -$187K 0.13% 220
2018
Q4
$272K Buy
80,710
+48,624
+152% +$164K 0.11% 229
2018
Q3
$209K Sell
32,086
-76,431
-70% -$498K 0.17% 208
2018
Q2
$831K Buy
+108,517
New +$831K 0.23% 152